Trial · NCT04271475
Results by group16
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 16 of 16
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in 6-minute Walk Distance (6MWD) at Week 28 | Double Blind (DB) Period: Macitentan | 9.7 | Standard Error 5.81 | Meters | |
| Change From Baseline in 6-minute Walk Distance (6MWD) at Week 28 | DB Period: Placebo | 25.8 | Standard Error 5.78 | Meters | |
| Time to First Clinical Event Committee (CEC) Confirmed Clinical Worsening up to End-of Double-blind-treatment (EODBT) Period | Double Blind (DB) Period: Macitentan | NA | 95% Confidence Interval 19.0 to NA | Months | |
| Time to First Clinical Event Committee (CEC) Confirmed Clinical Worsening up to End-of Double-blind-treatment (EODBT) Period | DB Period: Placebo | NA | 95% Confidence Interval NA to NA | Months | |
| Number of Participants With Improvement in World Health Organization Functional Class (WHO FC) From Baseline to Week 28 | Double Blind (DB) Period: Macitentan | 7 | Participants | ||
| Number of Participants With Improvement in World Health Organization Functional Class (WHO FC) From Baseline to Week 28 | DB Period: Placebo | 6 | Participants | ||
| Change From Baseline to Week 28 in Pulmonary Arterial Hypertension - Symptoms and Impact (PAH-SYMPACT) - Cardiopulmonary Symptom Domain Score | Double Blind (DB) Period: Macitentan | -0.089 | Standard Deviation 0.5856 | score on a scale | |
| Change From Baseline to Week 28 in Pulmonary Arterial Hypertension - Symptoms and Impact (PAH-SYMPACT) - Cardiopulmonary Symptom Domain Score | DB Period: Placebo | -0.060 | Standard Deviation 0.3767 | score on a scale | |
| Change From Baseline to Week 28 in PAH-SYMPACT - Cardiovascular Symptom Domain Score | Double Blind (DB) Period: Macitentan | -0.141 | Standard Deviation 0.4530 | Score on a scale | |
| Change From Baseline to Week 28 in PAH-SYMPACT - Cardiovascular Symptom Domain Score | DB Period: Placebo | -0.101 | Standard Deviation 0.2818 | Score on a scale | |
| Change From Baseline to Week 28 in Euro Quality of Life-5-Dimension-5-Level (EQ-5D-5L) Utility Score and Visual Analog Scale (VAS) Score | Double Blind (DB) Period: Macitentan | Utility score | 0.0472 | Standard Deviation 0.26700 | Score on a scale |
| Change From Baseline to Week 28 in Euro Quality of Life-5-Dimension-5-Level (EQ-5D-5L) Utility Score and Visual Analog Scale (VAS) Score | DB Period: Placebo | Utility score | 0.0050 | Standard Deviation 0.15010 | Score on a scale |
| Change From Baseline to Week 28 in Euro Quality of Life-5-Dimension-5-Level (EQ-5D-5L) Utility Score and Visual Analog Scale (VAS) Score | Double Blind (DB) Period: Macitentan | VAS score | 5.0 | Standard Deviation 17.65 | Score on a scale |
| Change From Baseline to Week 28 in Euro Quality of Life-5-Dimension-5-Level (EQ-5D-5L) Utility Score and Visual Analog Scale (VAS) Score | DB Period: Placebo | VAS score | 1.6 | Standard Deviation 11.97 | Score on a scale |
| Change From Baseline to Week 28 in Accelerometer-assessed Proportion of Time Spent in Moderate to Vigorous Physical Activity | Double Blind (DB) Period: Macitentan | 0.821 | Standard Deviation 3.9249 | Percent of minutes per day | |
| Change From Baseline to Week 28 in Accelerometer-assessed Proportion of Time Spent in Moderate to Vigorous Physical Activity | DB Period: Placebo | -0.833 | Standard Deviation 4.5160 | Percent of minutes per day |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04271475/results